Search Results 1091-1100 of 15489 for alt

  1. Phase I/II Study Of The Combination Of Blinatumomab And Asciminib In Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia - Mayo Clinic

    Alanine aminotransferase (ALT) ≤ 3 x ULN, OR 3. Aspartate aminotransferase (AST) ≤ 3 x ULN 5. Adequate renal function defined as: a) Creatinine clearance ...

  2. Non-Alcoholic Fatty Liver Disease Progression Prevention Using Lisinopril - Mayo Clinic

    syndrome. - Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT])/alanine aminotransferase (ALT) (serum glutamic pyruvic ...

  3. Define in Humans With Compensated CHF and Renal Dysfunction, the Modulating Action of Chronic AT1 Receptor Blockade in Addition to ACE Inhibition on Cardiorenal and Humoral Function - Mayo Clinic

    ALT >1.5 times the upper limit of normal; Serum sodium of < 125 mEq/dL or > 160 mEq/dL; Serum potassium of < 3.5 mEq/dL or > 5.7 mEq/dL; Serum digoxin level of ...

  4. P1101 in Treating Patients With Myelofibrosis - Mayo Clinic

    Alanine aminotransferase (ALT) =< 2.5 x ULN; Calculated creatinine clearance must be >= 50 ml/min using the Cockcroft-Gault formula; Negative pregnancy test ...

  5. Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations - Mayo Clinic

    AST (SGOT) and ALT (SGPT) ≤ 1.5 x ULN. Acceptable renal function with serum creatinine ≤ 1.5 x ULN or a calculated creatinine clearance ≥ 60 mL/min using ...

  6. Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma - Mayo Clinic

    Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) =< 3 x upper limit of normal (ULN); if liver metastases, =< 5 x upper limit of normal (ULN) ...

  7. Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients with Dumping Syndrome - Mayo Clinic

    ALT and AST > 2 x ULN. History of liver disease, such as cirrhosis or chronic active hepatitis B and C. Presence of Hepatitis B surface antigen (HbsAg) and ...

  8. A Study to Compare Radiation Therapy + Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer - Mayo Clinic

    ... (ALT) (serum glutamate pyruvate transaminase [SGPT]) ≤ 3.0 x ULN (AST and/or ALT ≤ 5 ULN for patients with liver involvement) (within 14 days prior to ...

  9. An Expanded Access Study of Iniparib Combined with Gemcitabine and Carboplatin for the Treatment of Breast Cancer - Mayo Clinic

    Serum creatinine ≤1.5 mg/dL or creatinine clearance ≥60 mL/min; alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤2.5 times the upper ...

  10. A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment - Mayo Clinic

    Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≤ 2.5 x upper limit of normal (ULN) (≤ 5 x ULN is acceptable if liver metastases are ...